Third Harmonic Bio: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Third Harmonic Bio (NASDAQ:THRD) reported its Q3 earnings, missing estimated earnings by 125.93% with an EPS of $-0.61 versus an estimate of $-0.27. Revenue was down $0 from the same period last year. Last quarter, the company beat on EPS by $0.11, which was followed by a 0.64% increase in the share price the next day.
November 09, 2023 | 1:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Third Harmonic Bio's Q3 earnings missed estimates significantly, which could negatively impact the stock price in the short term.
Third Harmonic Bio's earnings miss is a negative signal to investors, as it indicates the company's performance was worse than expected. This could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100